RCH-ACV: a lymphoblastic leukemia cell line with chromosome translocation 1;19 and trisomy 8

Area of Science:

• Hematology
• Oncology
• Cell Biology

Background:

• Acute lymphoblastic leukemia (ALL) is a heterogeneous cancer of lymphocytes.
• Pre-B acute lymphoblastic leukemia (pre-B-ALL) is a subtype often associated with a poor prognosis.
• The 1;19 chromosomal translocation is a recently identified genetic abnormality in pre-B-ALL.

Observation:

• A novel cell line, RCH-ACV, was established from the bone marrow of a pediatric patient with ALL.
• The RCH-ACV cell line was negative for Epstein-Barr virus nuclear antigen.
• Cytogenetic analysis revealed a nonrandom 1;19 translocation with a breakpoint at chromosome 19p13.3.

Findings:

• Cell surface marker analysis indicated a common ALL phenotype.
• Immunoglobulin gene rearrangement studies confirmed a pre-B cell phenotype, despite the absence of cytoplasmic immunoglobulin.
• The established cell line harbors the characteristic 1;19 translocation associated with pre-B-ALL.

Implications:

• The RCH-ACV cell line serves as a valuable research tool for investigating the pathogenesis of pre-B-ALL.
• This model can facilitate studies on the specific role of the 1;19 translocation in ALL development.
• Understanding the molecular mechanisms driven by the 1;19 translocation may lead to improved therapeutic strategies for pre-B-ALL.